Prostate cancer remains the most common cancer diagnosed for men in the United States, with an estimated 248 530 new cases and 34 130 deaths in 2021.1 The US Preventive Services Task Force (USPSTF) provides recommendations regarding the use of prostate-specific antigen (PSA) screening for prostate cancer. This evidence concerns the gene KLK3 and prostate cancer.